New pharmacological approaches to therapy of NIDDM

Rubin Bressler, David Johnson

Research output: Contribution to journalArticlepeer-review

74 Scopus citations


Currently available pharmacological agents have not been completely successful in restoring euglycemia in the non-insulin-dependent diabetes mellitus (NIDDM) patient. Several new approaches to the therapy of NIDDM have been formulated in recent years and are in various stages of laboratory or pharmaceutical development. Several of these agents are discussed in this article under categories relating to their mechanisms of lowering blood glucose: 1) inhibition of the release or action of counterregulatory hormones; 2) inhibition of postprandial glucose rise; 3) sensitization of tissues to insulin's actions; and 4) inhibition of gluconeogenesis, including inhibition of the long-chain acyl-CoA-carnitine acyltransferase I, the long-chain acylcarnitine translocase, and pyruvate carboxylase.

Original languageEnglish (US)
Pages (from-to)792-XI
JournalDiabetes care
Issue number6
StatePublished - Jun 1992

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing


Dive into the research topics of 'New pharmacological approaches to therapy of NIDDM'. Together they form a unique fingerprint.

Cite this